Condition
Relapsed B-cell Non-Hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Relapsed B-cell Non-Hodgkin Lymphoma clinical trials that are recruiting, at sites in 2 countries (most in China (1), South Africa (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
CD19 t-haNK and N-803 plus rituximab for relapsed or refractory B-cell non-Hodgkin lymphoma
This treatment tests whether giving lab-grown CD19-directed natural killer cells (t-haNK) together with N-803 and rituximab can help adults whose B-cell non-Hodgkin lymphoma has come back or not responded to prior therapy.
-
Treatment of relapsed or refractory B-cell non-Hodgkin lymphoma with LUCAR-20SP
This study is testing a new CAR-T cell therapy called LUCAR-20SP to see if it can help adults with tough cases of relapsed or refractory B-cell non-Hodgkin lymphoma.
Related topics
Quick answers
How many Relapsed B-cell Non-Hodgkin Lymphoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), South Africa (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.